Our commitment

Our 6,500 sq ft facility, strategically located in central Quilmes with direct access to public and private transport and just 30 minutes from Ezeiza International Airport, serves a metropolitan area of nearly 9 million residents. Purpose-built for pharmaco-clinical research, the site is currently undergoing expansion: renovations on the first level are underway, with an additional 3,200 sq ft soon to be added on the second floor, bringing the total to 9,700 sq ft. Research activities will be distributed across these levels as follows:

First Level:

From screening and informed consent to study visits and sample handling, every step is designed for seamless flow and participant comfort.

• 10 medical offices
• Pharmacy with Restricted access
• Controlled and constant room temperature
• Data logger with programmable readings and remote temperature change warning
• Power generator
• Laminar flow
• Biological safety cabinet
• Independent biological sample preparation area
• Central oxygen supply
• Crash cart
• Infusion pumps - Six infusion recliners
• Individual music - TV with cable connection – Handicapped WC
• Agreement with mobile coronary care unit
• Biological sample extraction, processing and kits storing area
• Refrigerator, Freezer and ultrafreezer
• Centrifuge and Refrigerated centrifuge
• Incubator for quantiferon simples
• Biological waste management
• Radiology, Bone densitometry, Electrocardiography, ultrasonography
• Breakfast, lunch and relaxation area for participants and employees

Second Level:

Second Level will house the clinical trial coordination, monitoring, quality assurance, and administration areas.

• Restricted access
• Individual lockers for the storing of specific documentation
• Central air conditioning,
• SC Individual workstations
• 4 monitoring boxes
• Meeting room
• Administrative area
• Direct IP phone lines, broadband Internet, and individual server
• Photocopier - Fax achine

With lean, scalable processes, we manage complex trials seamlessly—from documentation to advanced biological logistics—while upholding institutional excellence. Guided by a continuous PDCA cycle and full transparency, we deliver rigorous, efficient studies where innovation thrives and participant safety remains our highest priority.

At Instituto CER, we uphold the highest standards of quality, ensuring compliance with ICH GCP E6(R3) and local regulations to safeguard participant rights and data integrity. Our model combines proactive risk prevention, continuous improvement, and advanced technologies to deliver excellence in every trial.

Our Quality Framework

• Planning & Risk: Defining Critical-to-Quality (CtQ) factors and applying Risk-Based Quality Monitoring (RBQM).
• Operational Control: Robust SOPs, strict Trial Master File oversight, and document control.
• Audits & CAPA: Regular audits with thorough analysis and corrective/preventive action plans.
• Continuous Training: Ongoing education aligned with evolving regulations and site needs.
• Technology & Metrics: Centralized KPI dashboards and early-warning systems to ensure compliance and performance.

Result: A rigorous, technology-driven system that safeguards participants, ensures integrity, and drives efficient, reliable trials.

Equitable Access & Accelerated Recruitment

From an emerging country with underrepresented populations, we are committed to equity, autonomy, and respect. Patient recruitment is central to trial success, and at CER we combine strategic planning, community engagement, and operational excellence to accelerate enrollment without compromising ethics or quality.

Our Recruitment Pillars

• Proprietary patient databases
• A robust network of referring physicians
• Public awareness initiatives through our non-profit foundation
• A dedicated institutional communication agency

Result: Timely trial execution, reliable outcomes, and faster access to innovative therapies.

We design and execute a multichannel communication strategy that reinforces our scientific leadership, strengthens industry partnerships, and builds trust with patients.

For Patients

• Digital: Blog, newsletters, social media infographics, short videos
• Support: Secure patient portal, phone & WhatsApp assistance
• Engagement: Quarterly webinars, monthly Q&A sessions
• Tone: Clear, empowering, transparent, and appreciative

For Sponsors

• Thought Leadership: White papers, case studies, and technical articles highlighting GCP capabilities and phase II/III results
• Engagement: Specialized webinars and quarterly newsletters with pipeline updates, KPIs, and collaboration opportunities
• Strategic Alliances: One-on-one meetings and virtual roadshows to present tailored proposals and accelerate study acquisition

Result: A communication ecosystem that connects science, industry, and patients through transparency, expertise, and trust.

Founded in 2009 at the request of the CER Medical Institute, the Articular Foundation works to make clinical research accessible, inclusive, and rooted in trust. Every initiative seeks measurable social impact and improved well-being, guided by the highest ethical and scientific standards.

Our Pillars

• Social Inclusion: Free preventive healthcare campaigns for vulnerable populations.
• Diversity, Equity & Inclusion: Promoting participation of women, older adults, and minorities in clinical trials.
• Education & Dialogue: Empowering patients through open discussions and training.
• Ethics & Trust: Strengthening transparency, governance, and responsible communication.

Through these pillars, we transform science into a shared journey — where knowledge serves people, and people help shape the future of medicine.

Co-founded in 2018 by CER, CONICET, and the Articular Foundation, RadBio is a biotechnology startup dedicated to advanced diagnostic platforms and biopharmaceutical innovation. Operating independently yet closely linked to the national scientific ecosystem, RadBio transforms frontier research into real-world applications.

By strengthening translational medicine, biotechnology, and cross-sector collaborations, RadBio reinforces the forward-looking and innovative profile of the CER Medical Institute.